Purified proteins from Leishmania amastigotes-induced delayed type hypersensitivity reactions and remission of collagen-induced arthritis in animal models

Archives of Dermatological Research

Volumn 302, Issue 8, 2010, Pages 567-581

  O'Daly, Jose Antonio ^a   Gleason, J P ^a   Pena G ^a   Colorado, I ^a  

^a Astralis LTD   (United States)

Author keywords

Amastigotes antigens; Immunotherapy; Leishmania; Mice collagen model; Psoriatic arthritis; Rheumatoid arthritis

Indexed keywords

COLLAGEN; DEXAMETHASONE; FREUND ADJUVANT; LEISHMANIA ANTIGEN; PARASITE ANTIGEN; PHOSPHATE BUFFERED SALINE; PLACEBO; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG;

AMASTIGOTE; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DBA 1 MOUSE; DELAYED HYPERSENSITIVITY; FOREFOOT; GUINEA PIG; LEISHMANIA; MOUSE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROTEIN PURIFICATION; RANK SUM TEST; REMISSION; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTIGENS, PROTOZOAN; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CYTOKINES; GUINEA PIGS; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNOTHERAPY, ACTIVE; LEISHMANIA; MEMBRANE PROTEINS; MICE; PROTOZOAN VACCINES; RANDOM ALLOCATION; T-LYMPHOCYTES;

EID: 77958081962     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-009-1026-7     Document Type: Article

References (56)

1. Borg AA, Nixon NB, Dawes PT et al (1994) Increased IgA antibodies to cytokeratins in the spondyloarthropathies. Ann Rheum Dis 53:391-395
2. Boyle DL, Kavanaugh A (2008) The pathobiology of psoriatic synovium. Curr Opin Rheumatol 20:404-407
3. Boyman O, Conrad C, Dudli C et al (2005) Activation of dendritic antigen-presenting cells expressing common heat shock protein receptor CD91 during induction of psoriasis. Br J Dermatol 152:1211-1218
4. Chang X, Jian X, Yan X (2009) Expression and citrullination of keratin in synovial tissue of rheumatoid arthritis. Rheumatol Int 29:1337-1342
5. Christophers E, Mrowietz U (2003) Psoriasis. In: Freedberg IM, Eisen AZ, WolV K, Austen FK, Goldsmith LA, Katz SI (eds) Fitzpatrick's dermatology in general medicine, 6th edn. McGraw-Hill, New York, pp 407-427
6. Courtenay JS, Dallman MJ, Dayan AD et al (1980) Immunization against heterologous type II collagen induces arthritis in mice. Nature 283:666-668
7. De Rossell RA, Bray RS, Alexander J (1987) The correlation between delayed hypersensitivity, lymphocyte activation and protective immunity in experimental murine leishmaniasis. Parasite Immunol 9:105-115
8. Dinser R (2008) Animal models for arthritis. Best Pract Res Clin Rheumatol 22:253-267
9. Falgarone G, Semerano L, Rullé S et al (2009) Targeting lymphocyte activation to treat rheumatoid arthritis. Joint Bone Spine 76:327-332
10. Fournier C (2005) Where do T cells stand in rheumatoid arthritis? Joint Bone Spine 72:527-532
11. Gabriel SE, Michaud K (2009) Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 11:229. doi:10.1186/ar2669
12. Goëb V, Thomas-L'Otellier M, Daveau R et al (2009) Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes Arthritis Res Ther. doi:10.1186/ar2644
13. Hueber AJ, McInnes IB (2007) Immune regulation in psoriasis and psoriatic arthritis recent developments. Immunol Lett 114:59-65
14. Kemp M, Hansen MB, Theander TG (1992) Recognition of leishmania antigens by T lymphocytes from nonexposed individuals. Infect Immun 60:2246-2251
15. Klareskog L, Catrina AI, Paget S (2009) Rheumatoid arthritis. Lancet 373:659-672
16. Klein C, Wustefeld T, Assmus U et al (2005) The IL-6gp130-STAT3 pathway in hepatocytes triggers liver protection in T cellmediated liver injury. J Clin Invest 115:860-869
17. Kochetkova I, Trunkle T, Callis G et al (2008) Vaccination without autoantigen protects against collagen II-induced arthritis via immune deviation and regulatory T cells. J Immunol 181:2741-2752
18. Li L, Wang H, Wang B (2008) Anergic cells generated by blocking CD28 and CD40 costimulatory pathways in vitro ameliorate collagen induced arthritis. Cell Immunol 254:39-45
19. Li R, Li X, Li Z (2009) Altered collagen II 263-272 peptide immunization induces inhibition of collagen-induced arthritis through a shift toward Th2-type response. Tissue Antigens 73:341-347
20. Lowry OH, Rosebrough NJ, Farr AL et al (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275
21. Luross JA, Williams NA (2001) The genetic and immunopathological processes underlying collagen-induced arthritis. Immunology 103:407-416
22. Maciejewska H, Jüngel A, Gay RE et al (2009) Innate immunity, epigenetics and autoimmunity in rheumatoid arthritis. Mol Immunol 47:12-18
23. Mandik-Nayak L, Ridge N, Fields MJ et al (2008) Role of B cells in systemic lupus erythematosus and rheumatoid arthritis. Curr Opin Immunol 20:639-645
24. Myers KL, Terato K, Seyer JM et al (1992) Characterization of a tolerogenic T cell epitope of Type II collagen and its relevance to collagen-induced arthritis. J Immunol 149:1439-1443
25. Nandakumar KS (2010) Pathogenic antibody recognition of cartilage. Cell Tissue Res 339:213-220
26. Nandakumar KS, Bajtner E, Hill L et al (2008) Arthritogenic antibodies specific for a major type II collagen triple-helical epitope bind and destabilize cartilage independent of inflammation. Arthritis Rheum 58:184-196
27. Nickdel MB, Conigliaro P, Valesini G et al (2009) Dissecting the contribution of innate and antigen-specific pathways to the breach of self-tolerance observed in a murine model of arthritis. Ann Rheum Dis 68:1059-1066
28. O'Daly JA, Rodriguez B, Ovalles T et al (2009) Lymphocyte subsets in peripheral blood of patients with psoriasis before and after treatment with leishmania antigens. Arch Dermatol Res. doi:10.1007/s00403-009-0992-0
29. O'Daly JA, Lezama R, Gleason J (2009) Isolation of Leishmania amastigote protein fractions which induced lymphocyte stimulation and remission of psoriasis. Arch Dermatol Res 301:1-17
30. O'Daly JA, Lezama R, Rodriguez PJ et al (2009) Antigens from Leishmania amastigotes induced clinical remission of psoriasis. Arch Dermatol Res 301:1-13
31. O'Daly JA, Rodríguez MB (1988) Differential growth requirement of several Leishmania spp in chemically defined culture media. Acta Trop 45:109-126
32. O'Daly JA, Cebra JJ (1971) Rabbit secretory IgA III. Chemical and physicochemical studies of its component polypeptide chains. Biochemistry 10:3843-3850
33. O'Daly JA, Serrano L, Rodríguez MB (1983) Free amino-acid pool and proteolytic enzymes in Trypanosoma cruzi, cultured in vitro. Int J Parasitol 13:433-440
34. Passos MA, Barreto SM, Romanha AJ et al (2000) American cutaneous leishmaniasis: use of a skin test as a predictor of relapse after treatment. Bull World Health Organ 78:968-974
35. Pearson RD et al (1983) The immunobiology of leishmaniasis. Rev Infect Dis 5:907-927
36. Pratt AG, Isaacs JD, Mattey DL (2009) Current concepts in the pathogenesis of early rheumatoid arthritis. Best Pract Res Clin Rheumatol 23:37-48
37. Rajesh Rajaiah R, Moudgil KD (2009) Heat-shock proteins can promote as well as regulate autoimmunity. Autoimmun Rev 8:388-393
38. Rambukkana A, Das PK, Witkamp L et al (1993) Antibodies to mycobacterial 65-kDa heat shock protein and other immunodominant antigens in patients with psoriasis. J Invest Dermatol 100:87-92
39. Rat AC, Boissier MC (2004) Rheumatoid arthritis: direct and indirect costs. Joint Bone Spine 71:518-524
40. Rath A, Glibowicka M, Nadeau VG et al (2009) Detergent binding explains anomalous SDS-PAGE migration of membrane proteins. Proc Natl Acad Sci USA 106:1760-1765
41. Rooman RPA, Kuijpers G, Gresnigt R et al (2003) Dexamethasone differentially inhibits thyroxine-or growth hormone-induced body and organ growth of snell dwarf mice. Endocrinology 144:2553-2558
42. Rozenblit M, Lebwohl M (2009) New biologics for psoriasis and psoriatic arthritis. Dermatol Ther 22:56-60
43. Saravia NG, Weigle K, Segura I et al (1990) Recurrent lesions in human leishmania brasiliensis infection: reactivation or reinfection? Lancet 336:398-402
44. Segawa Y, Itokazu Y, Inoue N et al (2001) Possible changes in expression of chemotaxin LECT2 mRNA in mouse liver after Concanavalin A-induced hepatic injury. Biol Pharm Bull 24:425-428
45. Šenolt L, Vencovský J, K'Pavelka K et al (2009) Prospective new biological therapies for rheumatoid arthritis. Autoimmun Rev 9:102-107
46. Smith PK, Krohn RI, Hermanson GT et al (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85
47. Sokal JE (1975) Measurement of delayed skin test responses. N Engl J Med 293:501-502
48. Suzuki M, Konya C, Goronzy JJ et al (2008) Inhibitory CD8+ T cells in autoimmune disease. Hum Immunol 69:781-789
49. Terato K, Haeper DS, Griffiths MM et al (1995) Collagen-induced arthritis in mice: synergistic effect of E. coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen. Autoimmunity 22:137-147
50. Terato K, Hasty KA, Reife RA et al (1992) Induction of arthritis with monoclonal antibodies to collagen. J Immunol 148:2103-2108
51. Tiegs G, Henstchel J, Wendel A (1992) A T-cell dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 90:196-203
52. Uysal H, Bockermann R, Nandakumar KS et al (2009) Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis. J Exp Med 206:449-462
53. Ei Wakamatsu, Matsumoto I, Yoshiga y et al (2009) Altered peptide ligands regulate type II collagen-induced arthritis in mice. Mod Rheumatol 19:366-371
54. Winchester R (2003) Psoriatic arthritis. In: Freedberg IM, Eisen AZ, Wolff K, Austen FK, Goldsmith LA, Katz SI (eds) Fitzpatrick's dermatology in general medicine, 6th edn. McGraw-Hill, New York, pp 427-436
55. Xi C, Tan L, Sun y et al (2009) A novel recombinant peptide containing only two T-cell tolerance epitopes of chicken type II collagen that suppresses collagen-induced arthritis. Mol Immunol 46:729-737
56. Zügel U, Kaufmann SHE (1999) Role of heat shock proteins in protection from and pathogenesis of infectious diseases. Clin Microbiol Rev 12:19-39 (Pubitemid 29055952)